Visit
VJHemOnc is pleased to bring you a feature exploring the latest thinking on the application of MRD in AML trials…
VJHemOnc is thrilled to bring you the latest updates from the 64th American Society of Hematology (ASH) Annual Meeting and…
Learn how to build a social media strategy effectively and appropriately alongside your clinical practice. Independent medical support by Janssen…
Learn how to engage on Twitter alongside your clinical practice from leading hematology experts. Independent medical support by Janssen Pharmaceuticals
VJHemOnc is excited to bring you the latest research updates in myeloid malignancies from the EHA 2022 Congress, which took…
Learn how to use Twitter alongside your clinical practice from leading hematology experts. Independent medical support by Janssen Pharmaceuticals
VJHemOnc is excited to bring you the latest updates from research investigating the treatment and management of myeloid malignancies, as…
VJHemOnc is excited to bring you highlights from the 47th Annual Meeting of the European Group for Blood and Marrow…
A session with myelodysplastic syndromes (MDS) expert John Bennett who discusses MDS diagnosis and prognosis.
A session with experts Bruce Levine and Christian Chabannon, who discuss the exciting updates in transplantation and cell therapy from…
VJHemOnc brings you roundtable discussions with leading hematological experts in myeloma, AML, CLL, ALL, lymphoma, MDS and MPNs.
VJHemOnc is proud to present the SOHO Italy 2020 Virtual Meeting, which took place on the 22nd-24th of September 2020.
The American Society of Hematology (ASH) has worked in partnership with the McMaster GRADE Center to release new guidelines for…
In this session, Amer Zeidan, John Mascarenhas, Jan Bewersdorf & Rory Shallis discuss and debate the special considerations for managing…
Kiadis Pharma have filed the first investigational new drug (IND) application to the U.S. Food and Drug Administration (FDA) for…
By choosing to continue, you are confirming that you are a healthcare professional
Please enter your details if you would like to receive the latest hemonc news and updates
Keep up to date with all the latest news with our monthly newsletter